Navigation Links
Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress
Date:9/8/2009

ECCO 15 ESMO 34 will take place at the ICC Berlin Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany (www.icc-berlin.de) from Sunday 20 September to Thursday 24 September 2009.

There will be more than 2,000 presentations and over 15,000 participants from 120 countries, making it the largest European cancer congress to date.

The congress will discuss the latest advances in prevention, treatment and survivorship, proteomics, biomarkers, pharmacogenomics and imaging, as well as the latest evidence on epidemiological trends, complementary therapies and quality of life issues. For the first time, the meeting also features a patient advocacy track and a track on oncopolicy, which is aimed at strengthening European policy on cancer research and care.

There will be media news briefings at the following times:
Sunday 20 September, 16.00 hrs (CEST) in English (embargoed to Monday)
Monday 21 September, 11.00 hrs (CEST) in German
Tuesday 22 September, 11.15 hrs (CEST) in English
Wednesday 23 September, 11.15 hrs (CEST) in English

Here is a sample of the news results to be announced at the congress (embargoed to time of presentation at ECCO15-ESMO34):

  • Can aspirin prevent cancer in people with an inherited predisposition to colon cancer? International clinical trial has the answer.
  • Surgical removal of primary tumour improves survival in metastatic breast cancer patients.
  • Genetic identification of patients who are hypersensitive to radiotherapy helps improve treatment and avoid side-effects.
  • Potentially practice-changing results of phase III trial combining targeted heat therapy with chemotherapy in locally advanced soft tissue sarcoma.
  • Largest and most comprehensive study to date investigates links between prostate cancer hormone therapy and heart disease.
  • Largest study to date investigates the effect of whole-brain radiotherapy in patients with limited spread of primary cancer to the brain.
  • Meta-analysis clarifying the impact of adding cetuximab to various chemotherapy combinations in advanced non-small cell lung cancer.
  • Expert calls for new cancer research priorities and outlines strategy to cope with growing burden of cases.
  • Significant advances made in treatment of malignant melanoma: two trials show improvements in overall survival and rapid shrinking of tumours.
  • New results from SOLTI randomised trial on use of sorafenib in combination with chemotherapy in advanced breast cancer.
  • Could HPV vaccination and screening eradicate cervical cancer?
  • New figures on the numbers of new cancers in Europe caused by excess body fat.
  • Pancreatic cancer: researchers find drug that reverses resistance to chemotherapy.
  • New research on ultrasound shows it can predict tumour burden and survival in melanoma patients, sparing unnecessary surgery.
  • Innovative test for new cancer drugs will lead to quicker validation and safer and more efficient clinical trials.
  • Findings of the first study of teen experiences during the process of obtaining a cancer diagnosis.

ECCO (the European CanCer Organisation, which is organising the congress) and ESMO welcome the interest of the press in cancer issues and are happy to provide full assistance to journalists attending ECCO 15 ESMO 34, or using the congress website as a resource in their coverage of cancer issues. A media centre with computing, fax, photocopying and free international phone and internet connections will be available.

Press Office at ECCO 15 ESMO 34 opening times and telephone numbers:
Sunday 20 September 09.00 19.00 hrs (CEST)
Monday 21 Wednesday 23 September 08.00 19.00 hrs
Thursday 24 September 08.00 15.00 hrs
Tel: +49 30 3038 1006 and +49 30 3038 1007
Fax: +49 30 3038 1024
Press officers: Emma Mason, Mary Rice, Emma Ross, Susanne Werner

Registration and hotel accommodation

ECCO 15 ESMO 34 is open to bona fide representatives of print, electronic and broadcast media. For further details and media registration, visit the ECCO 15 ESMO 34 section of the ECCO website at: www.ecco-org.eu

NB: Media registration in advance is strongly recommended, and hotel rooms will go very quickly so early booking via the ECCO website is recommended.


'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-771-129-6986
ECCO-the European CanCer Organisation
Source:Eurekalert

Related medicine news :

1. Health Club Media Network Adds Crunch Health Club Chain
2. Census Bureau News Media Advisory: Census Bureau to Announce Findings for Income, Earnings, Poverty and Health Insurance Coverage
3. Advanced Health Media Named to 2009 Inc. 5000 List of Americas Fastest Growing Private Companies
4. AUDIO from Medialink, Boehringer Ingelheim Pharmaceuticals, Inc. & Pfizer Inc.: Coping with Chronic Obstructive Pulmonary Disease (COPD)
5. MPA Media Launches New Chiropractic Publication, Dynamic Chiropractic PracticeINSIGHTS
6. PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce
7. Robin Leedy & Associates Wins Social Media Program For Union Springs Pharmaceuticals
8. Bioelements Selects Room 214 as Their Social Media and Online Marketing Agency
9. Chronic Media Multi-Tasking Makes It Harder to Focus
10. Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time
11. ESC Congress 2009 media alert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Mary Magdalene: ... the mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace ... denizen, who spent her career as an educator interacting with countless women who had ...
(Date:1/20/2017)... ... ... “I Forgive You”: a fine examination of how God handles sin, including how to ... author, Stephen Miller, who, for over ten long years has been waiting to release this ... and Tobago, he has been serving the Lord for over twenty years, and he has ...
(Date:1/20/2017)... ... 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the ... a mother of three in Oklahoma City, and a devoted woman of faith. , ... has been in the back of my mind for years, but actually doing it might ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... , Jan. 19, 2017 Accuray Incorporated (Nasdaq: ... and TomoTherapy® Systems continue to set the bar for ... highest composite overall user satisfaction rating among radiation treatment ... 2016 MD Buyline Market Intelligence Briefing™. The most recent ... composite ratings among industry peers for 11 of the ...
(Date:1/19/2017)... , January 19, 2017 ... European Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement ... journal from touchONCOLOGY, an article by James ...
Breaking Medicine Technology: